Intriguingly, a third PCR band that migrates slightly lower than the 443 bp one seems to be preferentially expressed in BCC and SCC cancer samples, thus dictating the non-melanoma-dependent activation of additional MCT4 aberrant splicing events (Figure 2A,B). This evidence concerns the gene SLC16A3 and skin basal cell carcinoma.